glutathione refolding Protein - an overview Refolding in the modern biopharmaceutical
Description
Other potential health effects include neurotoxicity, genotoxicity, reproductive toxicity, hepatotoxicity, immunotoxicity, and increased cardiovascular risk
10.1177/1756287214528557 71 TsaoC-K.CuttingE.MartinJ.OhW
Some people take it once daily, while others split it into two servings (for example, one in the morning and one later in the day)
The FDA first approved the drug in 1984
There is also the concern of delivery systems due to poor targeting and off-target toxicity
